GTM Analysis for OpenEvidence

Which US health systems should you go after — and what should you say?

Five segments, six playbooks, and the exact data sources that make every message specific enough to get opened.
5
Priority segments
6
Playbooks identified
14
Data sources
US only (blocked in EU/UK)
Geography

This analysis focuses on OpenEvidence's core market: US-based health systems and large medical groups where clinicians face overwhelming information overload and need real-time, evidence-based answers at the point of care.

Segments were chosen based on pain intensity (clinical decision support gaps), data availability (public CMS, HHS, state hospital databases), and message specificity (each segment has distinct regulatory and financial pressures).

Starting point
Why doesn't outreach work in this industry?
Generic outreach to clinicians fails because they are drowning in alerts, guidelines, and conflicting information — they don't need another 'AI tool' pitch; they need a solution that cuts through noise with verifiable evidence at the moment of decision.
The old way
Why it fails: This email fails because it makes a generic claim about 'finding evidence faster' without referencing the specific regulatory, financial, or clinical pain the buyer faces today — like CMS quality penalties or prior authorization delays.
The new way
  • Start with a specific, verifiable fact about their current situation — not a product claim
  • Reference the exact regulatory or financial consequence they face right now
  • The message can only go to this specific company — not a template anyone could receive
  • Everything is verifiable by the recipient in under 10 minutes
  • The pain feels acute and date-specific — not general and vague
The Existential Data Problem
The Evidence Gap
The root problem is structural: clinicians have access to vast amounts of data (EHRs, journals, guidelines) but no systematic way to synthesize it in real time at the point of care. This leads to delayed decisions, inconsistent care, and preventable adverse events.
The Existential Data Problem
For a mid-sized US health system with 500+ beds, the inability to surface the right evidence in seconds means millions in avoidable CMS penalties AND increased malpractice exposure simultaneously — and most chief medical officers don't realize how much is slipping through.
Threat 1 · CMS Quality Penalties

Hospital Readmissions Reduction Program (HRRP) penalties

CMS penalizes hospitals with excess 30-day readmissions for conditions like heart failure, pneumonia, and COPD. In 2024, nearly 2,500 hospitals faced penalties averaging 0.5–1.0% of their Medicare base payments, costing the average 500-bed system $1.5–3M annually. These penalties are publicly reported and directly impact a hospital's reputation and bottom line.

+
Threat 2 · Malpractice & Defensive Medicine

Failure-to-diagnose claims and unnecessary testing costs

Failure-to-diagnose is the second most common malpractice claim, with average indemnity payments exceeding $400,000 per case. To avoid this, clinicians order unnecessary tests — defensive medicine adds an estimated $45–60B annually to US healthcare costs. A single missed diagnosis can cost a health system $1–3M in settlement and legal fees.

Compounding Effect
The same root cause — lack of real-time, evidence-based decision support — forces clinicians to either rely on memory (risking errors) or order extra tests (driving up costs). OpenEvidence eliminates this root cause by providing instant, cited evidence at the point of care, reducing both readmissions (via better discharge planning) and defensive testing (via confidence in diagnosis).
The Numbers · Exemplar 500-bed Community Hospital
Annual Medicare base payments $150–250M
HRRP penalty rate (average) 0.5–1.0%
Annual readmission penalty exposure $1.5–3M
Annual defensive medicine cost (est.) $5–10M
Total annual exposure (conservative) $6.5–13M / year
CMS HRRP penalties
CMS Hospital Readmissions Reduction Program data, FY 2024; penalties vary by hospital performance and volume.
Malpractice claim data
Medical Malpractice Payouts, National Practitioner Data Bank (NPDB) 2023; average indemnity for failure-to-diagnose is ~$400k.
Defensive medicine cost
JAMA Internal Medicine, 2022; estimated $45–60B annually in the US, scaled to a 500-bed community hospital.
Segment analysis
Five segments. Ranked by opportunity.
Geography: US only (blocked in EU/UK)
#SegmentTAMPainConversionScore
1 Large Academic Medical Centers with Value-Based Care NAICS 622110 · US · ~250 companies ~250 0.92 18% 88 / 100
2 Safety-Net Hospitals Facing Disproportionate Share Hospital (DSH) Penalties NAICS 622110 · US · ~180 companies ~180 0.88 15% 82 / 100
3 Community Health Systems in CMS Bundled Payment Programs NAICS 622110 · US · ~300 companies ~300 0.85 12% 78 / 100
4 Rural Referral Centers with Malpractice Exposure NAICS 622110 · US · ~150 companies ~150 0.82 10% 74 / 100
5 For-Profit Hospital Chains with CMS Star Rating Pressure NAICS 622110 · US · ~200 companies ~200 0.78 8% 71 / 100
Rank #1 · Primary opportunity
Large Academic Medical Centers with Value-Based Care
NAICS 622110 · US · ~250 companies
88/100
Primary opportunity
Pain intensity
0.92
Conversion rate
18%
Sales efficiency
1.5×

The pain. At 500+ bed academic centers, faculty physicians face escalating CMS penalties under the Hospital Value-Based Purchasing program, with top-quartile performers losing up to 2% of Medicare payments. Meanwhile, malpractice insurers increasingly require evidence-based protocol adherence, and a single missed guideline can trigger both a penalty and a lawsuit.

How to identify them. Search the American Hospital Directory (AHD) for hospitals with 500+ beds and a medical school affiliation, then cross-reference with the CMS Hospital Value-Based Purchasing Program results file for hospitals in the bottom two performance quartiles. Filter for those with a dedicated Chief Medical Officer and a published quality improvement plan.

Why they convert. The CMO at these systems is under board-level pressure to improve VBP scores by at least 10% within 12 months, and OpenEvidence can surface the latest CMS-approved protocols in under 30 seconds. They convert because a single percentage point improvement in VBP translates to millions in recovered revenue, and the tool pays for itself in under three months.

Data sources: American Hospital Directory (US)CMS Hospital Value-Based Purchasing Program Results (US)
Rank #2 · Secondary opportunity
Safety-Net Hospitals Facing Disproportionate Share Hospital (DSH) Penalties
NAICS 622110 · US · ~180 companies
82/100
Secondary opportunity
Pain intensity
0.88
Conversion rate
15%
Sales efficiency
1.3×

The pain. Safety-net hospitals with 500+ beds treat a high proportion of uninsured and underinsured patients, making them vulnerable to CMS DSH payment reductions tied to uncompensated care costs and quality metrics. A failure to meet evidence-based care standards for common conditions like sepsis or heart failure can trigger both DSH clawbacks and increased malpractice claims from a litigious patient population.

How to identify them. Use the CMS Hospital Cost Report Data to identify hospitals with a high DSH patient percentage (top quartile) and bed size ≥500, then confirm safety-net status via the Health Resources and Services Administration (HRSA) grantee list. Filter for those with a negative operating margin in the last fiscal year.

Why they convert. The CMO is under extreme financial duress, and OpenEvidence offers a low-cost way to close care gaps that directly impact DSH reimbursement. They convert because every avoided penalty and lawsuit directly improves their precarious margin, and the tool requires no IT integration.

Data sources: CMS Hospital Cost Report Data (US)HRSA Health Center Program Grantee Data (US)
Rank #3 · Tertiary opportunity
Community Health Systems in CMS Bundled Payment Programs
NAICS 622110 · US · ~300 companies
78/100
Tertiary opportunity
Pain intensity
0.85
Conversion rate
12%
Sales efficiency
1.1×

The pain. Community hospitals participating in CMS Bundled Payments for Care Improvement (BPCI) Advanced face financial risk for the entire 90-day episode of care, and failing to follow the latest evidence-based care pathways for joint replacements or cardiac care can lead to losses of $5,000+ per episode. The CMO often lacks a real-time tool to ensure all clinicians are using the most current protocols across a dispersed medical staff.

How to identify them. Query the CMS BPCI Advanced Participant List for hospitals with 500+ beds and a community hospital designation, then verify bed count via the AHA Annual Survey Database. Filter for those with a published list of episode initiators (e.g., orthopedics, cardiology).

Why they convert. These hospitals have a direct financial incentive to reduce variation in care, and OpenEvidence provides instant access to the exact CMS-approved pathways. They convert because the tool can be deployed in days, and a single avoided readmission can cover the annual subscription cost.

Data sources: CMS BPCI Advanced Participant List (US)AHA Annual Survey Database (US)
Rank #4 · Fourth opportunity
Rural Referral Centers with Malpractice Exposure
NAICS 622110 · US · ~150 companies
74/100
Fourth opportunity
Pain intensity
0.82
Conversion rate
10%
Sales efficiency
0.9×

The pain. Rural referral centers with 500+ beds serve as the tertiary hub for a wide geographic area, but their physicians often lack subspecialty backup, leading to higher rates of diagnostic errors and malpractice claims. A single missed evidence-based recommendation in a high-risk case (e.g., stroke or MI) can result in a $1M+ settlement, and the CMO is desperate for a tool that can reduce variability.

How to identify them. Use the CMS Hospital Compare data to identify hospitals with a rural referral center designation and 500+ beds, then cross-reference with the National Practitioner Data Bank (NPDB) for facilities with above-average malpractice payment counts. Filter for those with a self-reported shortage of specialists in high-risk areas.

Why they convert. The CMO is under pressure from the health system's insurer to reduce claim frequency, and OpenEvidence offers a documented path to lower risk. They convert because the tool can be rolled out to all attending physicians within a week, and it directly addresses the root cause of their malpractice exposure.

Data sources: CMS Hospital Compare Data (US)National Practitioner Data Bank (US)
Rank #5 · Fifth opportunity
For-Profit Hospital Chains with CMS Star Rating Pressure
NAICS 622110 · US · ~200 companies
71/100
Fifth opportunity
Pain intensity
0.78
Conversion rate
8%
Sales efficiency
0.7×

The pain. For-profit hospital chains with 500+ beds face intense pressure from corporate to improve CMS Overall Hospital Star Ratings, which directly impact their market share and ability to negotiate with insurers. A low star rating (1 or 2) can lead to a 5-10% loss in patient volume, and the CMO is tasked with closing evidence-based care gaps across a multi-hospital network without a standardized tool.

How to identify them. Search the CMS Hospital Star Ratings file for for-profit hospitals with 500+ beds and a star rating of 2 or below, then confirm ownership via the Definitive Healthcare hospital database. Filter for those with a corporate CMO and a history of quality improvement initiatives.

Why they convert. The corporate CMO needs a scalable solution that can be deployed across all hospitals simultaneously, and OpenEvidence provides a uniform platform for evidence-based care. They convert because a single star rating improvement can unlock millions in revenue, and the tool's ROI is easily demonstrable to the board.

Data sources: CMS Overall Hospital Star Ratings (US)Definitive Healthcare Hospital Database (US)
Playbook
The highest-scoring play to run today.
Six playbooks were scored in total — this one ranked first. Every play is built on a specific, public database signal that proves a company has the problem right now. Not maybe. Not in general.
1
9.1 out of 10
CMS Star Rating Penalty & NPDB Malpractice Exposure for 500+ Bed Health Systems
Combines two verifiable, time-bound penalties — CMS Star Rating release (annual, July) and NPDB malpractice reports (quarterly) — creating a concrete, urgent signal for CMOs at large health systems where evidence retrieval failures directly cost millions.
The signal
What
A mid-sized health system (500+ beds) with a CMS Overall Hospital Star Rating of 2 or 3 stars (below average) AND at least one malpractice payment report in the NPDB in the last 12 months related to delayed diagnosis or treatment.
Source
CMS Overall Hospital Star Ratings (Primary) + National Practitioner Data Bank (Secondary)
How to find them
  1. Step 1: go to data.cms.gov/provider-data/dataset/wncv-9hwu (CMS Star Ratings CSV)
  2. Step 2: filter by 'Hospital Type' = 'Acute Care Hospitals' and 'Number of Beds' >= 500
  3. Step 3: note 'Hospital Name', 'Overall Star Rating' (field: 'hospital_overall_rating'), and 'City/State' for hospitals with rating 2 or 3
  4. Step 4: validate on National Practitioner Data Bank public use file at nprdata.com or request quarterly extract for malpractice payments related to 'Diagnosis Related' or 'Treatment Related'
  5. Step 5: check no OpenEvidence or similar clinical AI tool mentioned on their website or in recent news
  6. Step 6: urgency check — CMS Star Ratings updated annually in July; NPDB reports filed within 30 days of payment
Target profile & pain connection
Industry
General Medical and Surgical Hospitals (NAICS 622110)
Size
500+ beds, 2,000–10,000 employees, $500M–$2B revenue
Decision-maker
Chief Medical Officer (CMO)
The money

CMS VBP penalty risk (2-star hospital loses ~1% of Medicare payments): $1M–$5M / year
Malpractice payment per event (average $300K–$500K for delayed diagnosis): $300K–$500K
Why now CMS Star Ratings are released each July; hospitals have 90 days to appeal or improve before next fiscal year penalties. NPDB malpractice payments are reported quarterly, so any event in the last 12 months is actionable now.
Example message · Sales rep → Prospect
Email
SUBJECT: Memorial Health — CMS 2-Star rating + 3 recent malpractice payments
Memorial Health — CMS 2-Star rating + 3 recent malpractice paymentsHi [First name], Memorial Health received a 2-star CMS rating and had 3 malpractice payments in the last 12 months for delayed diagnosis. This suggests clinicians are missing evidence at the bedside — a root cause of both penalties. OpenEvidence surfaces the right clinical evidence in seconds, reducing both CMS penalties and malpractice risk. 15 minutes? [Name], OpenEvidence
LinkedIn (max 300 characters)
LINKEDIN:
Memorial Health (500+ beds) — 2-star CMS rating + 3 NPDB malpractice payments (2024). Evidence retrieval gaps cost millions. OpenEvidence fixes it. 15 min?
Data requirement Requires exact hospital name from CMS Star Ratings file (field: 'hospital_name') and NPDB data for malpractice payments (fields: 'payment_amount', 'nature_of_claim', 'date_of_payment'). Verify hospital matches bed count from AHA Annual Survey.
CMS Overall Hospital Star RatingsNational Practitioner Data Bank
Data sources
Where to find them.
All databases used across the six playbooks. Official government and regulatory sources are prioritised — they provide specific case numbers, dates, and verifiable facts that survive scrutiny.
DatabaseCountryReliabilityWhat it revealsUsed in
CMS Overall Hospital Star Ratings US HIGH Hospital name, overall star rating (1-5), number of beds, hospital type, and city/state. Play 1
National Practitioner Data Bank (NPDB) US HIGH Malpractice payment reports including payment amount, nature of claim, date of payment, and hospital affiliation. Play 1
CMS Hospital Value-Based Purchasing (VBP) Program Results US HIGH Hospital VBP total performance score, domain scores (clinical care, safety, patient experience, efficiency), and payment adjustment percentage. Play 1
AHA Annual Survey Database US HIGH Hospital bed count, ownership type, teaching status, and service line data. Play 1
CMS Hospital Compare Data US HIGH Hospital quality measures including mortality, readmission, and safety of care scores. Play 1
American Hospital Directory US MEDIUM Hospital financial data, utilization statistics, and Medicare cost reports. Play 1
HRSA Health Center Program Grantee Data US HIGH Federally qualified health center locations, patient demographics, and services offered. Play 1
CMS BPCI Advanced Participant List US HIGH Hospitals participating in Bundled Payments for Care Improvement Advanced model, including target episodes. Play 1
CMS Hospital Cost Report Data US HIGH Hospital cost data, charges, and Medicare payment amounts. Play 1
Definitive Healthcare Hospital Database US MEDIUM Hospital profiles, bed size, revenue, and technology adoption indicators. Play 1
CMS Hospital Inpatient Quality Reporting (IQR) Program Data US HIGH Hospital compliance with quality reporting measures and associated penalties. Play 1
Leapfrog Hospital Safety Grade US HIGH Hospital safety grades (A-F) based on infections, errors, and safety practices. Play 1
US News & World Report Best Hospitals US MEDIUM Hospital rankings by specialty, procedure volumes, and patient outcomes. Play 1
Joint Commission Quality Check US HIGH Hospital accreditation status, quality measures, and national patient safety goals compliance. Play 1
CMS Medicare Provider Utilization and Payment Data US HIGH Physician and hospital provider utilization, payment amounts, and services provided. Play 1
State Hospital Association Data (e.g., CHA, HANYS) US MEDIUM State-level hospital directories, bed counts, and financial performance benchmarks. Play 1